Nova Patents
NO855213L

Oxetanone

Abstract

Es werden neue die Pankreaslipase hemmende Oxetanonäthylester der Formel worin R' -R5 und n die in der Beschreibung angegebene Bedeutung haben, und Salze dieser Ester mit schwachen Säuren ausgehend von entsprechenden Oxetanonäthanolen hergestellt.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

47 members in 25 offices

This recordMember, by publication datePriority claim15 more offices are in the list below

Priority claims5

Priority claims
DocumentOfficeKindDate
610284SwitzerlandA
393485SwitzerlandA
846102
CH19840006102
CH19850003934

Members47

Family members, oldest first
DocumentOfficeKind
FI854797A0FinlandA0
DK600385D0DenmarkD0
PT81748APortugalA
ZW20385A1ZimbabweA1
GR853048BGreeceB
IE853277LIrelandL
DK600385ADenmarkA
FI854797AFinlandA
FI854797A7FinlandA7
NO855213LThis recordNorwayL
EP0185359A2European Patent Office (EPO)A2
AU5125985AAustraliaA
CN85108888AChinaA
JPS61152663AJapanA
KR860004865ARepublic of KoreaA
ZA859575BSouth AfricaB
HUT39440AHungaryA
MC1728A1MonacoA1
EP0185359A3European Patent Office (EPO)A3
ES8708219A1SpainA1
PT81748BPortugalB
CS262425B2Czechoslovakia (until 1993)B2
AU583569B2AustraliaB2
NZ214565ANew ZealandA
HU200172BHungaryB
US4931463AUnited States of AmericaA
CA1270837ACanadaA
ES556896A0SpainA0
ES9100003A1SpainA1
IL77338AIsraelA
DOP1985004386ADominican RepublicA
CN1012643BChinaB
EP0185359B1European Patent Office (EPO)B1
AT70061TAustriaT
ATE70061T1AustriaT1
DE3584829D1GermanyD1
PH26291APhilippinesA
NO171160BNorwayB
US5175186AUnited States of AmericaA
NO171160CNorwayC
JPH0529226B2JapanB2
DK166724B1DenmarkB1
US5246960AUnited States of AmericaA
IE58926B1IrelandB1
FI91403BFinlandB
FI91403CFinlandC
KR950008310B1Republic of KoreaB1